<SEC-DOCUMENT>0001628280-26-058937-index.html : 20260825
<SEC-HEADER>0001628280-26-058937.hdr.sgml : 20260825
<ACCEPTANCE-DATETIME>20260825165804
ACCESSION NUMBER: 0001628280-26-058937
CONFORMED SUBMISSION TYPE: 8-K
PUBLIC DOCUMENT COUNT: 12
CONFORMED PERIOD OF REPORT: 20260821
ITEM INFORMATION: Entry into a Material Definitive Agreement
ITEM INFORMATION: Financial Statements and Exhibits
FILED AS OF DATE: 20260825
DATE AS OF CHANGE: 20260825

FILER:

 COMPANY DATA: 
 COMPANY CONFORMED NAME: Bicara Therapeutics Inc.
 CENTRAL INDEX KEY: 0002023658
 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
 ORGANIZATION NAME: 03 Life Sciences
 EIN: 000000000
 STATE OF INCORPORATION: DE
 FISCAL YEAR END: 1231

 FILING VALUES:
 FORM TYPE: 8-K
 SEC ACT: 1934 Act
 SEC FILE NUMBER: 001-42271
 FILM NUMBER: 261316627

 BUSINESS ADDRESS: 
 STREET 1: 116 HUNTINGTON AVENUE SUITE 703
 CITY: BOSTON
 STATE: MA
 ZIP: 02116
 BUSINESS PHONE: 617-468-4219

 MAIL ADDRESS: 
 STREET 1: 116 HUNTINGTON AVENUE SUITE 703
 CITY: BOSTON
 STATE: MA
 ZIP: 02116
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bcax-20260821.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: bcax-20260821.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a10stjamesbicaratherapeuti.htm
<DESCRIPTION>EX-10.1
<TEXT>
Document 2 - file: a10stjamesbicaratherapeuti.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>bcax-20260821.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
Document 3 - file: bcax-20260821.xsd

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>bcax-20260821_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
Document 4 - file: bcax-20260821_lab.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>bcax-20260821_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
Document 5 - file: bcax-20260821_pre.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 7 - file: R1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 8 - file: report.css

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 9 - file: Show.js

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 11 - file: FilingSummary.html

Document 11 - RAW XML: FilingSummary.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 13 - file: MetaLinks.json

</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001628280-26-058937-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 14 - file: 0001628280-26-058937-xbrl.zip

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>bcax-20260821_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 15 - file: bcax-20260821_htm.html

Document 15 - RAW XML: bcax-20260821_htm.xml

</DOCUMENT>
</SEC-DOCUMENT>